FASN and melanoma: Reasoning that fatty acid synthesis and the subsequent relative reduction of membrane lipid poly-unsaturation are important for the development of therapy resistance, we inhibited this pathway in DT-resistant 451lu R and D10 BMR melanoma cells in combination with the potent and selective FASN inhibitor TVB-3664 [15].